| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |